Effectiveness of Hydrogen Rich Water on Antioxidant Status of Subjects with Potential Metabolic Syndrome—An Open Label Pilot Study
Atsunori Nakao, Yoshiya Toyoda, Prachi Sharma, Malkanthi Evans, Najla Guthrie
Journal of Clinical Biochemistry and Nutrition · 2010 · 46(2) · 140–149
Abstract
Metabolic syndrome is characterized by cardiometabolic risk factors that include obesity, insulin resistance, hypertension and dyslipidemia. Oxidative stress is known to play a major role in the pathogenesis of metabolic syndrome. The objective of this study was to examine the effectiveness of hydrogen rich water (1.5–2 L/day) in an open label, 8-week study on 20 subjects with potential metabolic syndrome. Hydrogen rich water was produced, by placing a metallic magnesium stick into drinking water (hydrogen concentration; 0.55–0.65 mM), by the following chemical reaction; Mg + 2H2O → Mg (OH)2 + H2. The consumption of hydrogen rich water for 8 weeks resulted in a 39% increase (p<0.05) in antioxidant enzyme superoxide dismutase (SOD) and a 43% decrease (p<0.05) in thiobarbituric acid reactive substances (TBARS) in urine. Further, subjects demonstrated an 8% increase in high density lipoprotein (HDL)-cholesterol and a 13% decrease in total cholesterol/HDL-cholesterol from baseline to week 4. There was no change in fasting glucose levels during the 8 week study. In conclusion, drinking hydrogen rich water represents a potentially novel therapeutic and preventive strategy for metabolic syndrome. The portable magnesium stick was a safe, easy and effective method of delivering hydrogen rich water for daily consumption by participants in the study.
Study details
- Article type
- Original Research
- Disease / injury model
- Potential Metabolic Syndrome (pre-hypertensive, pre-diabetic, dyslipidemia, overweight/obese)
- Duration
- 8 weeks
- Dose-dependent effect
- No
- Outcome
- Positive
- Findings
- Drinking hydrogen-rich water for 8 weeks in subjects with potential metabolic syndrome resulted in a significant increase in antioxidant enzyme SOD, a significant decrease in urinary TBARS, an increase in HDL-cholesterol, and a decrease in total cholesterol/HDL ratio, with no change in fasting glucose. The method was safe and well-tolerated.
Classification
- Study Type
- Study Design
- Species
- Physiological Systems
- Biomarkers
- 8-hydroxy-2' -deoxyguanosine (8-OHdG)8-IsoprostaneAlanine aminotransferase (ALT)Aspartate Aminotransferase (AST)BilirubinCreatinine (Cr)Fasting Blood Glucose (FBG)Gamma-Glutamyl Transferase (GGT)Glomerular Filtration Rate (GFR)HDL-Cholesterol (HDL-C)LDL-Cholesterol (LDL-C)Superoxide Dismutase (SOD)Thiobarbituric acid reactive substances (TBARS)Total cholesterol/HDL-cholesterol ratioTriglycerides (TAG)
- Methods of Administration
- Countries
- Also
- Highlighted Articles
